Can heparin-induced thrombocytopenia be associated with fondaparinux use? Reply to a rebuttal

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 7, 2008, Pages 1243-1246

  Warkentin, Theodore E ^a   Lim, W ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY PF4; DANAPAROID; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADRENAL VEIN THROMBOSIS; ADULT; ANAMNESIS; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DEEP VEIN THROMBOSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERCOAGULABILITY; IMMUNOASSAY; INFLAMMATION; INTERMETHOD COMPARISON; NOTE; PREOPERATIVE CARE; PRIORITY JOURNAL; SEROTONIN RELEASE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; TOTAL HIP PROSTHESIS; VEIN THROMBOSIS;

EID: 45549095823     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02972.x     Document Type: Note

References (15)

1. Warkentin TE, Mauter BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007; 356: 2653-4.
2. Warkentin TE, Cook RJ, Marder VJ, Sheppard JI, Moore JC, Eriksson BI, Greinacher A, Kelton JG. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood 2005; 106: 3791-6. [Epub 2005 Aug 18].
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79: 1-7.
4. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5.
5. Greinacher A, Michels I, Schäfer M, Kiefel V, Mueller-Eckhardt C. Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: Evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan. Br J Haematol 1992; 81: 252-4.
6. Tardy-Poncet B, Tardy B, Grelac F, Reynaud J, Mismetti P, Bertrand JC, Guyotat D. Pentosan polysulfate-induced thrombocytopenia and thrombosis. Am J Hematol 1994; 45: 252-7.
7. Rosenthal MA, Rischin D, McArthur G, Ribbons K, Chong B, Fareed J, Toner G, Green MD, Basser RL. Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia. Ann Oncol 2002; 13: 770-6.
8. Prechel MM, McDonald MK, Jeske WP, Messmore HL, Walenga JM. Activation of platelet by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin. J Thromb Haemost 2005; 3: 2168-75.
9. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135: 502-6.
10. Warkentin TE, Jay RM, Makris M, Kelton JG. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am J Med 2008; in press.
11. Warkentin TE. Pseudo-heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia. New York: Marcel Dekker, Inc, 2000: 245-60.
12. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 3(Suppl.): 311S-37S.
13. Farner B, Eichler P, Kroll H, Greinacher A. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thromb Haemost 2001; 85: 950-7.
14. Rota E, Bazzan M, Fantino G. Fondaparinux-related thrombocytopenia in a previous low-molecular weight heparin (LMWH)-induced heparin-induced thrombocytopenia. Thromb Haemost 2008; 99: 779-81.
15. Lobo B, Finch C, Howard A, Minhas S. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Thromb Haemost 2008; 99: 208-14.